Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Diabetes Obes Metab. 2016 Jun 14;18(9):899–906. doi: 10.1111/dom.12686

Table 2.

Predictive statistics of 10-year risk prediction models

Continuous NRI Categorical NRI
(25% predicted risk cut-point)

C-statistic
(95% CI)
Difference
in C-
statistic
(95% CI)
P-value
for
difference
Overall
NRI
(95% CI)*
Event NRI
(95% CI)*
Non-event
NRI
(95% CI)*
Overall NRI
(95% CI)*
Event NRI
(95% CI)*
Non-event
NRI
(95% CI)*
Relative
IDI
(95% CI)*

Model 1 (Self- reported) 0.667 (0.64, 0.70) -- -- -- -- -- --
Model 2 (+ clinical variables) 0.683 (0.65, 0.71) 0.016 (0.00, 0.03) 0.032 0.42 (0.26, 0.56) 0.18 (0.07, 0.29) 0.23 (0.13, 0.34) 0.07 (0.03, 0.12) -0.02 (−0.04, 0.00) 0.09 (0.06, 0.14) 0.28 (0.21, 0.36)
Model 3 (+ HbA1c) 0.694 (0.66, 0.72) 0.011 (0.00, 0.02) 0.021 0.25 (0.11, 0.40) −0.02 (−0.13, 0.10) 0.27 (0.17, 0.37) 0.02 (−0.01, 0.06) 0.01 (−0.01, 0.03) 0.02 (−0.01, 0.05) 0.08 (0.04, 0.11)
Model 4 (+ additional biomarkers) 0.716 (0.69, 0.74) 0.022§ (0.01, 0.04) 0.003§ 0.32§ (0.17, 0.47) 0.14§ (0.04, 0.25) 0.18§ (0.07, 0.29) 0.03§ (−0.02, 0.07) −0.03§ (−0.06, −0.01) 0.06§ (0.02, 0.09) 0.15§ (0.09, 0.22)
*

Bias-corrected 95% CIs are reported for NRI and IDI,and were obtained usingbootstrap with 1,000replications

vs. Model 1

vs. Model 2

§

vs. Model 3

Model 1 includes age, sex, race, education, smoking status, alcohol consumption, physical activity, family history of CVD, glucose-lowering medication use, antihypertensive medication use, cholesterol-lowering medication use, recent onset of diabetes, BMI, interaction of sex with glucose-lowering medication use, and interaction of race with BMI.

Model 2 additionally includes LDL-c, HDL-c, triglycerides, systolic blood pressure, interaction of sex with triglycerides, and interaction of race with triglycerides.

Model 3 additionally includes HbA1c.

Model 4 additionally includes 1/B2M, eGFR-Cr, and eGFR-CysC.